Potential advantages of acute kidney injury management by mesenchymal stem cells

doi:10.4252/wjsc.v6.i5.644

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15763)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

638

WORD

372

HTML

9724

Figures (1-1)

1010

Tables (1-1)

448

Sum=12192

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1676

Download

1895

Sum=3571

Nov 26, 2014 (publication date) through Oct 30, 2025

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Stem Cells. Nov 26, 2014; 6(5): 644-650
Published online Nov 26, 2014. doi: 10.4252/wjsc.v6.i5.644

Open in New Tab Full Size Figure Download Figure

Figure 1 Therapeutic potential of mesenchymal stem cells and their derivatives. MSCs: Mesenchymal stem cells; GDNF: Glial derived-cell line neurotrophic factor; VEGF: Vascular endothelial growth factor.

Citation: Bianchi F, Sala E, Donadei C, Capelli I, La Manna G. Potential advantages of acute kidney injury management by mesenchymal stem cells. World J Stem Cells 2014; 6(5): 644-650
URL: https://www.wjgnet.com/1948-0210/full/v6/i5/644.htm
DOI: https://dx.doi.org/10.4252/wjsc.v6.i5.644